PPH ETF

$110.63

Returns Overview

1 Month
+5.23%
3 Months
+11.05%
6 Months
+4.83%
YTD
+8.15%
1 Year
+27.11%
3 Years (annualized)
+13.78%
5 Years (annualized)
+10.53%
10 Years (annualized)
+8.46%

Risk Metrics (1-Year)

No risk data available for this ETF

Stress Test Scenarios

How would PPH have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
🔒Upgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
🔒Upgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
🔒Upgrade to run

1 Month Performance

+5.23%

3 Months Performance

+11.05%

6 Months Performance

+4.83%

1 Year Performance

+27.11%

Benchmark & Peers

Benchmark
MVIS US Listed Pharmaceutical 25 Index(^MVPPH)
This ETF (YTD)
+8.15%
Peer Avg (YTD)
+7.57%
vs Peers
+0.58%

PPH ETF Performance

PPH performance across multiple time periods: 1-month 5.23%, YTD 8.15%, 1-year 27.11%, 3-year 13.78%, 5-year 10.53%, 10-year 8.46%.

PPH returns outperform the peer average of 7.57% YTD. With an expense ratio of 0.36%, investors should weigh costs against performance when evaluating this ETF.

PPH performance comparison shows side-by-side returns with another fund. PPH alternatives are available in the ETF Screener.

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal ReturnDate Range
1 Month+5.23%Jun 24, 2026 to Jul 24, 2026
3 Months+11.05%Apr 24, 2026 to Jul 24, 2026
6 Months+4.83%Jan 26, 2026 to Jul 24, 2026
1 Year+27.11%N/A
3 Years+13.78%N/A
5 Years+10.53%N/A

Periods up to 1 year are total returns; 3, 5 and 10 year figures are annualized